Structural analysis and mapping of DNase I hypersensitivity of HS5 of the β-globin locus control region

Genomics

Volumn 61, Issue 2, 1999, Pages 183-193

  Li, Qiliang ^a   Zhang, Miaohua ^a   Duan, Zhijun ^a   Stamatoyannopoulos, George ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN; DEOXYRIBONUCLEASE;

ARTICLE; GENE EXPRESSION SYSTEM; GENE LOCUS; GENE MAPPING; GENE SEQUENCE; GENE STRUCTURE; HUMAN; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REGULATOR GENE; SEQUENCE ANALYSIS;

GALAGO; MURINAE; RODENTIA;

EID: 0033569326     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1999.5954     Document Type: Article

References (57)

1. Andrews N. C., Faller D. V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19:1991;2499.
2. Andrews N. C., Erdjument-Bromage H., Davidson M. B., Tempst P., Orkin S. H. Erythroid transcription factor NF-E2 is a hematopoietic-specific basic-leucine zipper protein. Nature. 362:1993;722-728.
3. Armstrong J. A., Emerson B. M. NF-E2 disrupts chromatin structure at human β-globin locus control region hypersensitive site 2 in vitro. Mol. Cell. Biol. 16:1996;5634-5644.
4. Bender M. A., Reik A., Close J., Telling A., Epner E., Fiering S., Hardison R., Groudine M. Description and targeted deletion of 5′ hypersensitive site 5 and 6 of the mouse β-globin locus control region. Blood. 92:1998;4394-4403.
5. Bungert J., Dave U., Lim K-C., Lieuw K. H., Shavit J. A., Liu Q., Engel J. D. Synergistic regulation of human β-globin gene switching by locus control region elements HS3 and HS4. Genes Dev. 9:1995;3083-3096.
6. Bungert J., Tanimoto K., Patel S., Liu Q., Fear M., Engel J. D. Hypersensitive site 2 specifies a unique function within the human β-globin locus control region to stimulate globin gene transcription. Mol. Cell. Biol. 19:1999;3062-3072.
7. Caterina J. J., Ryan T. M., Pawlik K. M., Palmiter R. D., Brinster R. L., Behringer R. R., Townes T. M. Human β-globin locus control region: Analysis of the 5′ DNase I hypersensitive site HS2 in transgenic mice. Proc. Natl. Acad. Sci. USA. 88:1991;1626-1630.
8. Chung J. H., Whiteley M., Felsenfeld G. A 5′ element of the chicken b-globin domain serves as an insulator in human erythroid cells as protects against position effect in Drosophila. Cell. 74:1993;505-514.
9. Collis P., Antoniou M., Grosveld F. Definition of the minimal requirements within the human β-globin gene and the dominant control region for high level expression. EMBO J. 9:1990;233-240.
10. Dhar V., Nandi A., Schildkraut C. L., Skoutchi A. Erythroid-specific nuclease-hypersensitive sites flanking the human b-globin domain. Mol. Cell. Biol. 10:1990;4324-4333.
11. Engel J. D. Developmental regulation of human β-globin gene transcription: A switch of loyalties? Trends Genet. 9:1993;304-309.
12. Felsenfeld G. Chromatin as an essential part of the transcriptional mechanism. Nature. 355:1992;219-224.
13. Fernandes M., Xiao H., Lis J. T. Fine structure analysis of the Drosophila and Saccharomyces heat shock factor-heat shock element interaction. Nucleic Acids Res. 22:1994;167-173.
14. Fiering S., Epner E., Robinson K., Zhuang Y., Telling A., Hu M., Martin D. I. K., Enver T., Ley T. J., Groudine M. Targeted deletion of 5′HS2 of the murine β-globin LCR reveals that it is not essential for proper regulation of the β-globin locus. Genes Dev. 9:1995;2203-2213.
15. Forrester W. C., Thompson C., Elder J. T., Groudine M. A developmentally stable chromatin structure in the human β-globin gene cluster. Proc. Natl. Acad. Sci. USA. 83:1986;1359-1363.
16. Forrester W. C., Novak U., Gelinas R., Groudine M. Molecular analysis of the human β-globin locus activation region. Proc. Natl. Acad. Sci. USA. 86:1989;5439-5443.
17. Fraser P., Hurst J., Collis P., Grosveld F. DNase I hypersensitive sites 1, 2 and 3 of the human β-globin dominant control region direct position-independent expression. Nucleic Acids Res. 18:1990;3503-3508.
18. Fraser P., Pruzina S., Antoniou M., Grosveld F. Each hypersensitive site of the human β-globin locus control region confers a different developmental pattern of expression on the globin genes. Genes Dev. 7:1993;106-113.
19. Gong Q. H., McDowell J. C., Dean A. Essential role of NF-E2 in remodeling of chromatin structure and transcriptional activation of the epsilon-globin gene in vivo by 5′ hypersensitive site 2 of the beta-globin locus control region. Mol. Cell. Biol. 16:1996;6055-6064.
20. Grosveld F., van Assendelft G. B., Greaves D. R., Kollias G. Position-independent, high-level expression of the human β-globin gene in transgenic mice. Cell. 51:1987;975-985.
21. Grosveld F., Dillon N., Higgs D. The regulation of human globin gene expression. Bailieres Clin. Haematol. 6:1993;31-55.
22. Hardison R. C., Slightom J. L., Gumucio D. L., Goodman M., Stojanovic N., Miller W. Locus control regions of mammalian β-globin gene clusters: Combining phylogenetic analyses and experimental results to gain functional insights. Gene. 205:1997;73-94.
23. Hardison R., Riemer C., Chui D. H. K., Huisman T. H. J., Miller W. Electronic access to sequence alignments, experimental results, and human mutations as an aid to studying globin gene regulation. Genomics. 47:1998;429-437.
24. Hug B. A., Wesselschmidt R. L., Fiering S., Bender M. A., Epner E., Groudine M., Ley T. J. Analysis of mice containing a targeted deletion of β-globin locus control region 5′ hypersensitive site 3. Mol. Cell. Biol. 16:1996;2906-2912.
25. Ikuta T., Papayannopoulou T., Stamatoyannopoulos G., Kan Y. W. Globin gene switching: In vivo protein-DNA interactions of the human β-globin locus in erythroid cells expressing the fetal or the adult globin gene program. J. Biol. Chem. 271:1996;14082-14091.
26. Jimenez G., Gale K. B., Enver T. The mouse β-globin locus control region: Hypersensitive sites 3 and 4. Nucleic Acids Res. 20:1992;5797-5803.
27. Li Q., Zhou B., Powers P., Enver T., Stamatoyannopoulos G. β-globin locus activation regions: Conservation of organization, structure, and function. Proc. Natl. Acad. Sci. USA. 87:1990;8207-8211.
28. Li Q., Stamatoyannopoulos G. Hypersensitive site 5 of the human β locus control region functions as a chromatin insulator. Blood. 84:1994a;1399-1401.
29. Li Q., Stamatoyannopoulos J. A. Position independence and proper developmental control of γ-globin gene expression require both a 5′ locus control region and a downstream sequence element. Mol. Cell. Biol. 14:1994b;6087-6096.
30. Liu D., Chang J. C., Moi P., Liu W., Kan Y. W., Curtin P. T. Dissection of the enhancer activity of β-globin 5′ DNase I-hypersensitive site 2 in transgenic mice. Proc. Natl. Acad. Sci. USA. 89:1992;3899-3903.
31. Long Q., Bengra C., Li C., Kutlar F., Tuan D. A long terminal repeat of the human endogenous retrovirus ERV-9 is located in the 5′ boundary area of the human β-globin locus control region. Genomics. 54:1998;542-555.
32. Margalit Y., Yarus S., Shapira E., Gruenbaum Y., Fainsod A. Isolation and characterization of target sequences of the chicken CdxA homeobox gene. Nucleic Acids Res. 21:1993;4915-4922.
33. Martin D. I., Fiering S., Groudine M. Regulation of β-globin gene expression: Straightening out the locus. Curr. Opin. Genet. Dev. 6:1996;488-495.
34. Meyers S., Downing J. R., Hiebert S. W. Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding protein: The runt homology domain is required for DNA binding and protein-protein interaction. Mol. Cell. Biol. 13:1993;6336-6345.
35. Milot E., Strouboulis J., Trimborn T., Wijgerde M., de Boer E., Langeveld A., Tan-Un K., Vergeer W., Yannoutsos N., Grosveld F., Fraser P. Heterochromatin effects on the frequency and duration of LCR-mediated gene transcription. Cell. 87:1996;105-114.
36. Moon A. M., Ley T. J. Conservation of the primary structure, organization, and function of the human and mouse b-globin locus-activating region. Proc. Natl. Acad. Sci. USA. 87:1990;7693-7697.
37. Navas P. A., Peterson K. R., Li Qiliang, Skarpidi E., Rohde A., Shaw S. E., Clegg C. H., Asano H., Stamatoyannopoulos G. Transgenic mice with HS3 core deletion: Direct evidence for developmental specificity of the interaction between the LCR and the embryonic or fetal globin genes. Mol. Cell. Biol. 18:1998;4188-4196.
38. Orkin S. H. Globin gene regulation and switching: Circa 1990. Cell. 63:1990;665-672.
39. Orkin S. H. Regulation of globin gene expression in erythroid cells. Eur. J. Biochem. 231:1995;271-281.
40. Peterson K. R., Clegg C. H., Navas P. A., Norton E. J., Kimbrough T. G., Stamatoyannopoulos G. Effect of deletion of 5′ HS3 or 5′HS2 of the human β-globin locus control region on the developmental regulation of globin gene expression in β-globin locus yeast artificial chromosome transgenic mice. Proc. Natl. Acad. Sci. USA. 93:1996;6605-6609.
41. Philipsen S., Talbot D., Fraser P., Grosveld F. The β-globin dominant control region: Hypersensitive site 2. EMBO J. 9:1990;2159-2167.
42. Pruzina S., Hanscombe O., Whyatt D., Grosveld F., Philipsen S. Hypersensitive site 4 of the human β globin locus control region. Nucleic Acids Res. 19:1991;1413-1419.
43. Reddy P. M. S., Shen C.-K. J. Protein-DNA interaction in vivo of an erythroid-specific, human β-globin locus enhancer. Proc. Natl. Acad. Sci. USA. 88:1991;8676-8680.
44. Ryan T. M., Behringer R. R., Martin N. C., Townes T. M., Palmiter R. D., Brinster R. L. A single erythroid-specific DNase I super-hypersensitive site activates high levels of human β-globin gene expression in transgenic mice. Genes Dev. 3:1989;314-323.
45. Slightom J. L., Bock J. H., Tagle D. A., Gumucio D. L., Goodman M., Stojanovic N., Jackson J., Miller W., Hardison R. The complete sequences of the galago and rabbit β-globin locus control regions: Extended sequence and functional conservation outside the cores of DNase hypersensitive sites. Genomics. 39:1997;90-94.
46. Stamatoyannopoulos G., Nienhuis A. W. Hemoglobin switching. Stamatoyannopoulos G., Nienhuis A. W., Majerus P., Varmus H. The Molecular Basis of Blood Diseases. 1994;107-155 Saunders, Philadelphia.
47. Stamatoyannopoulos J. A., Goodwin A., Joyce T., Lowrey C. H. NF-E2 and GATA binding motifs are required for the formation of DNase I hypersensitive site 4 of the human β-globin locus control region. EMBO J. 14:1995;106-116.
48. Strauss E. C., Orkin S. H. In vivo protein-DNA interaction at hypersensitive site 3 of the human β-globin locus control region. Proc. Natl. Acad. Sci. USA. 89:1992;5809-5813.
49. Tagle D. A., Koop B. F., Goodman M., Slightom J. L., Hess D., Jones R. T. Embryonic ε and γ globin genes of a prosimian primate (Galago crassicaudatis): Nucleotide and amino acid sequence, developmental regulation, and phylogenetic footprints. J. Mol. Biol. 203:1988;439-455.
50. Talbot D., Collis P., Antoniou M., Vidal M., Grosveld F., Greaves D. R. A dominant control region from the human β-globin locus conferring integration site-independent gene expression. Nature. 338:1989;352-355.
51. Talbot D., Philipsen S., Fraser P., Grosveld. F. Detailed analysis of the site 3 region of the human β-globin dominant control region. EMBO J. 9:1990;2169-2178.
52. Townes T. M., Behringer R. R. Human globin locus activation region (LAR): Role in temporal control. Trends Genet. 6:1990;219-223.
53. Tuan D., Solomon W., Li Q., London I. M. The β-like globin gene domain in human erythroid cells. Proc. Natl. Acad. Sci. USA. 82:1995;6384-6388.
54. Wijgerde M., Grosveld F., Fraser P. Transcription complex stability and chromatin dynamics in vivo. Nature. 377:1995;209-213.
55. Wood W. G. The complexities of β-globin gene regulation. Trends Genet. 12:1996;204-206.
56. Yu J., Bock J. H., Slightom J. L., Villeponteau B. A 5′ β-globin matrix-attachment region and the polyoma enhancer together confer position-independent transcription. Gene. 139:1994;139-154.
57. Zafarana G., Raguz S., Pruzina S., Grosveld F., Meijer D. The regulation of human β-globin gene expression: The analysis of hypersensitive site 5 (HS5) in the LCR. Stamatoyannopoulos G. Hemoglobin Switching. 1994;39-44 Intercept Ltd. Hampshire.